Literature DB >> 16087865

Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.

Jian Wang1, Taku Yoshida, Fumio Nakaki, Hiroshi Hiai, Taku Okazaki, Tasuku Honjo.   

Abstract

Mice deficient in programmed cell death 1 (PD-1, Pdcd1), an immunoinhibitory receptor belonging to the CD28/cytotoxic T lymphocyte-associated antigen-4 family, spontaneously develop lupus-like autoimmune disease and autoimmune dilated cardiomyopathy on C57BL/6 and BALB/c backgrounds, respectively. However, how PD-1 deficiency induces different forms of autoimmune diseases on these two strains was unknown. Here, we report that PD-1 deficiency specifically accelerates the onset and frequency of type I diabetes in NOD (nonobese diabetic) mice, with strong T helper 1 polarization of T cells infiltrating into islets. These results suggest that PD-1 deficiency accelerates autoimmune predisposition of the background strain, leading to the induction of different forms of autoimmune diseases depending on the genetic background of the strain. Using NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes, we screened diabetes-susceptible loci by genetic linkage analysis. The diabetic incidence of NOD-Pdcd1-/- mice was controlled by five genetic loci, including three known recessive loci [Idd (insulin-dependent diabetes) 1, Idd17, and Idd20] and two previously unidentified dominant loci [Iddp (Idd under PD-1 deficiency) 1 and Iddp2].

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087865      PMCID: PMC1188011          DOI: 10.1073/pnas.0505497102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.

Authors:  Saskia C A van Blokland; Marjan A Versnel
Journal:  Clin Immunol       Date:  2002-05       Impact factor: 3.969

2.  Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells.

Authors:  Kenji Tanigaki; Hua Han; Norio Yamamoto; Kei Tashiro; Masaya Ikegawa; Kazuki Kuroda; Akira Suzuki; Toru Nakano; Tasuku Honjo
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

Review 3.  Understanding autoimmune diabetes: insights from mouse models.

Authors:  Luciano Adorini; Silvia Gregori; Leonard C Harrison
Journal:  Trends Mol Med       Date:  2002-01       Impact factor: 11.951

4.  Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice.

Authors:  Nathalie Deruytter; Olivier Boulard; Henri-Jean Garchon
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

5.  Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.

Authors:  Taku Okazaki; Yoshimasa Tanaka; Ryosuke Nishio; Tamotsu Mitsuiye; Akira Mizoguchi; Jian Wang; Masayoshi Ishida; Hiroshi Hiai; Akira Matsumori; Nagahiro Minato; Tasuku Honjo
Journal:  Nat Med       Date:  2003-11-02       Impact factor: 53.440

6.  PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.

Authors:  Yvette E Latchman; Spencer C Liang; Yin Wu; Tatyana Chernova; Raymond A Sobel; Martina Klemm; Vijay K Kuchroo; Gordon J Freeman; Arlene H Sharpe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.

Authors:  Gil-Jin Shim; Margaret Warner; Hyun-Jin Kim; Sandra Andersson; Lining Liu; Jenny Ekman; Otabek Imamov; Margaret E Jones; Evan R Simpson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

8.  Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.

Authors:  Sumit K Subudhi; Ping Zhou; Lisa M Yerian; Robert K Chin; James C Lo; Robert A Anders; Yonglian Sun; Lieping Chen; Yang Wang; Maria-Luisa Alegre; Yang-Xin Fu
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice.

Authors:  Peggy L Kendall; Emily J Woodward; Chrys Hulbert; James W Thomas
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

Review 10.  Susceptibility genes in the pathogenesis of murine lupus.

Authors:  Charles Nguyen; Nisha Limaye; Edward K Wakeland
Journal:  Arthritis Res       Date:  2002-05-09
View more
  175 in total

Review 1.  PD-1, gender, and autoimmunity.

Authors:  Ravi K Dinesh; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-28       Impact factor: 9.754

2.  PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.

Authors:  Victor Peña-Cruz; Sean M McDonough; Felipe Diaz-Griffero; Christopher P Crum; Ruben D Carrasco; Gordon J Freeman
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

Review 3.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 4.  Role of PD-L1 and PD-L2 in allergic diseases and asthma.

Authors:  A K Singh; P Stock; O Akbari
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

5.  PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses.

Authors:  Victor D Fedorov; Maria Themeli; Michel Sadelain
Journal:  Sci Transl Med       Date:  2013-12-11       Impact factor: 17.956

Review 6.  The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility.

Authors:  Marta E Alarcón-Riquelme
Journal:  Springer Semin Immunopathol       Date:  2006-09-09

7.  Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Authors:  Kristen E Pauken; Christine E Nelson; Tijana Martinov; Vaiva Vezys; Brian T Fife; Justin A Spanier; James R Heffernan; Nathanael L Sahli; Clare F Quarnstrom; Kevin C Osum; Jason M Schenkel; Marc K Jenkins; Bruce R Blazar
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

Review 8.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

Review 9.  Engineering better immunotherapies via RNA interference.

Authors:  Mouldy Sioud
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 10.  Heart failure in cancer: role of checkpoint inhibitors.

Authors:  Murilo Delgobo; Stefan Frantz
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.